{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:40:45Z","timestamp":1767901245726,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,25]]},"DOI":"10.7759\/cureus.95369","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T09:08:37Z","timestamp":1761383317000},"source":"Crossref","is-referenced-by-count":1,"title":["Association of Oncogenic Viral Infections With Cardiovascular Risk and Health Outcomes: A Cross-Sectional Study in South Asian Adults"],"prefix":"10.7759","author":[{"given":"Yashar","family":"Mashayekhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasleem","family":"Tasleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Faiq","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvelous  O","family":"Popoola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thel Su","family":"Hlaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehnaz","family":"Mahboob Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ibrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahim","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-5151(11)00111-3","article-title":"The global burden of cardiovascular disease","volume":"1016","author":"Deaton C","year":"2011","unstructured":"Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs. 2011, 1016:1474-5151. 10.1016\/s1474-5151(11)00111-3","journal-title":"Eur J Cardiovasc Nurs"},{"key":"ref2","unstructured":"World Health Organization. Cardiovascular diseases (CVDs). (2023). Accessed: July 31, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref3","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. (2024). Accessed: July 31, 2025: https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"ref4","unstructured":"World Health Organization. Cervical cancer. (2024). Accessed. 2025 Jul 31: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac249","article-title":"Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy","volume":"43","author":"Joseph P","year":"2022","unstructured":"Joseph P, Kutty VR, Mohan V, et al.. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. Eur Heart J. 2022, 43:2831-40. 10.1093\/eurheartj\/ehac249","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295670","article-title":"HBV prevalence in sub-continental countries: a systematic review and meta-analysis","volume":"18","author":"Hogan S","year":"2023","unstructured":"Hogan S, Page A, Dixit S, McBride KA. HBV prevalence in sub-continental countries: a systematic review and meta-analysis. PLoS One. 2023, 18:e0295670. 10.1371\/journal.pone.0295670","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29350","article-title":"Association between chronic viral infection-related hospitalization and risk of cardiovascular disease: a\u00a0population-based cohort study","volume":"96","author":"Yang L","year":"2024","unstructured":"Yang L, Lu Z, Bian J, Li F, Zou H. Association between chronic viral infection-related hospitalization and risk of cardiovascular disease: a\u00a0population-based cohort study. J Med Virol. 2024, 96:e29350. 10.1002\/jmv.29350","journal-title":"J Med Virol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2018.09.003","article-title":"More than just oncogenes: mechanisms of tumorigenesis by human viruses","volume":"32","author":"Gaglia MM","year":"2018","unstructured":"Gaglia MM, Munger K. More than just oncogenes: mechanisms of tumorigenesis by human viruses. Curr Opin Virol. 2018, 32:48-59. 10.1016\/j.coviro.2018.09.003","journal-title":"Curr Opin Virol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2016.0109","article-title":"Oncogenic role of tumor viruses in humans","volume":"30","author":"Akram N","year":"2017","unstructured":"Akram N, Imran M, Noreen M, Ahmed F, Atif M, Fatima Z, Bilal Waqar A. Oncogenic role of tumor viruses in humans. Viral Immunol. 2017, 30:20-7. 10.1089\/vim.2016.0109","journal-title":"Viral Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab315","article-title":"Cardiovascular consequences of viral infections: from COVID to other viral diseases","volume":"117","author":"Schultheiss HP","year":"2021","unstructured":"Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res. 2021, 117:2610-23. 10.1093\/cvr\/cvab315","journal-title":"Cardiovasc Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1030440","article-title":"Persistent viral infections and their role in heart disease","volume":"13","author":"Badrinath A","year":"2022","unstructured":"Badrinath A, Bhatta S, Kloc A. Persistent viral infections and their role in heart disease. Front Microbiol. 2022, 13:1030440. 10.3389\/fmicb.2022.1030440","journal-title":"Front Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.44.5.950","article-title":"Virus and the heart","volume":"44","author":"Abelmann WH","year":"1971","unstructured":"Abelmann WH. Virus and the heart. Circulation. 1971, 44:950-6. 10.1161\/01.cir.44.5.950","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306102","article-title":"Cardiovascular diseases and HCV infection: a simple association or more?","volume":"63","author":"Petta S","year":"2014","unstructured":"Petta S, Macaluso FS, Crax\u00ec A. Cardiovascular diseases and HCV infection: a simple association or more?. Gut. 2014, 63:369-75. 10.1136\/gutjnl-2013-306102","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.7.5.691","article-title":"Persistent infection and vascular disease: a systematic review","volume":"7","author":"Danesh J","year":"1998","unstructured":"Danesh J, Appleby P. Persistent infection and vascular disease: a systematic review. Expert Opin Investig Drugs. 1998, 7:691-713. 10.1517\/13543784.7.5.691","journal-title":"Expert Opin Investig Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2024.02.001","article-title":"Unveiling HPV's hidden link: cardiovascular diseases and the viral intrigue","volume":"76","author":"Dutta P","year":"2024","unstructured":"Dutta P, Saha D, Earle M, et al.. Unveiling HPV's hidden link: cardiovascular diseases and the viral intrigue. Indian Heart J. 2024, 76:1-5. 10.1016\/j.ihj.2024.02.001","journal-title":"Indian Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.11.12","article-title":"Hepatitis B virus infection and risk of coronary artery disease: a meta-analysis","volume":"4","author":"Wijarnpreecha K","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Hepatitis B virus infection and risk of coronary artery disease: a meta-analysis. Ann Transl Med. 2016, 4:423. 10.21037\/atm.2016.11.12","journal-title":"Ann Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188330","article-title":"Cardiovascular involvement in Epstein-Barr virus infection","volume":"14","author":"Chen X","year":"2023","unstructured":"Chen X, Li Y, Deng L, et al.. Cardiovascular involvement in Epstein-Barr virus infection. Front Immunol. 2023, 14:1188330. 10.3389\/fimmu.2023.1188330","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81919-0","article-title":"Kaposi's sarcoma-associated herpesvirus immune modulation: an overview","volume":"87","author":"Rezaee SA","year":"2006","unstructured":"Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol. 2006, 87:1781-804. 10.1099\/vir.0.81919-0","journal-title":"J Gen Virol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1789.2000.00320.x","article-title":"HTLV-I-associated myelopathy","volume":"20","author":"Izumo S","year":"2000","unstructured":"Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy. Neuropathology. 2000, 20:S65-8. 10.1046\/j.1440-1789.2000.00320.x","journal-title":"Neuropathology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01694-7","article-title":"Sample size calculation for prevalence studies using Scalex and ScalaR calculators","volume":"22","author":"Naing L","year":"2022","unstructured":"Naing L, Nordin RB, Abdul Rahman H, Naing YT. Sample size calculation for prevalence studies using Scalex and ScalaR calculators. BMC Med Res Methodol. 2022, 22:209. 10.1186\/s12874-022-01694-7","journal-title":"BMC Med Res Methodol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green CP","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000, 35:1245-55. 10.1016\/s0735-1097(00)00531-3","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq448","article-title":"Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score","volume":"32","author":"McGorrian C","year":"2011","unstructured":"McGorrian C, Yusuf S, Islam S, et al.. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J. 2011, 32:581-9. 10.1093\/eurheartj\/ehq448","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf S","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, et al.. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364:937-52. 10.1016\/s0140-6736(04)17018-9","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/09622802221107105","article-title":"Adjusting for time of infection or positive test when estimating the risk of a post-infection outcome in an epidemic","volume":"31","author":"Seaman SR","year":"2022","unstructured":"Seaman SR, Nyberg T, Overton CE, Pascall DJ, Presanis AM, De Angelis D. Adjusting for time of infection or positive test when estimating the risk of a post-infection outcome in an epidemic. Stat Methods Med Res. 2022, 31:1942-58. 10.1177\/09622802221107105","journal-title":"Stat Methods Med Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho GY","year":"1998","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338:423-8. 10.1056\/NEJM199802123380703","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-017-0108-x","article-title":"Hepatitis C: review of the epidemiology, clinical care, and continued challenges in the direct acting antiviral era","volume":"4","author":"Millman AJ","year":"2017","unstructured":"Millman AJ, Nelson NP, Vellozzi C. Hepatitis C: review of the epidemiology, clinical care, and continued challenges in the direct acting antiviral era. Curr Epidemiol Rep. 2017, 4:174-85. 10.1007\/s40471-017-0108-x","journal-title":"Curr Epidemiol Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0748-8","article-title":"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits","volume":"15","author":"Smith-Palmer J","year":"2015","unstructured":"Smith-Palmer J, Cerri K, Valentine W. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infect Dis. 2015, 15:19. 10.1186\/s12879-015-0748-8","journal-title":"BMC Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14808","article-title":"The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four European countries","volume":"41","author":"Mennini FS","year":"2021","unstructured":"Mennini FS, Marcellusi A, Robbins Scott S, et al.. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four European countries. Liver Int. 2021, 41:934-48. 10.1111\/liv.14808","journal-title":"Liver Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2497608","article-title":"Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: a systematic literature review","volume":"21","author":"Harper DM","year":"2025","unstructured":"Harper DM, Navarro-Alonso JA, Bosch FX, et al.. Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: a systematic literature review. Hum Vaccin Immunother. 2025, 21:2497608. 10.1080\/21645515.2025.2497608","journal-title":"Hum Vaccin Immunother"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2700.96484","article-title":"Correlation of C-reactive protein to severity of symptoms in acute influenza A infection","volume":"5","author":"Haran JP","year":"2012","unstructured":"Haran JP, Suner S, Gardiner F. Correlation of C-reactive protein to severity of symptoms in acute influenza A infection. J Emerg Trauma Shock. 2012, 5:149-52. 10.4103\/0974-2700.96484","journal-title":"J Emerg Trauma Shock"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2013.154","article-title":"Management of infections in critically ill patients","volume":"15","author":"Hranjec T","year":"2014","unstructured":"Hranjec T, Sawyer RG. Management of infections in critically ill patients. Surg Infect (Larchmt). 2014, 15:474-8. 10.1089\/sur.2013.154","journal-title":"Surg Infect (Larchmt)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw411","article-title":"Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study","volume":"38","author":"Mohseni H","year":"2017","unstructured":"Mohseni H, Kiran A, Khorshidi R, Rahimi K. Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study. Eur Heart J. 2017, 38:326-33. 10.1093\/eurheartj\/ehw411","journal-title":"Eur Heart J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12892","article-title":"Heart rate as a predictor of cardiovascular risk","volume":"48","author":"Tadic M","year":"2018","unstructured":"Tadic M, Cuspidi C, Grassi G. Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest. 2018, 48:10.1111\/eci.12892","journal-title":"Eur J Clin Invest"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-02155-8_4","article-title":"Sex differences in susceptibility to viral infection","author":"Klein SL","year":"2009","unstructured":"Klein SL, Huber S. Sex differences in susceptibility to viral infection. Sex Hormones and Immunity to Infection. Klein SL, Roberts C (ed): Springer-Verlag, Berlin, Heidelberg; 2009. 93-122. 10.1007\/978-3-642-02155-8_4"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1310\/hct1106-340","article-title":"Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-na\u00efve HIV-infected individuals initiating combination antiretroviral therapy","volume":"11","author":"Raboud J","year":"2010","unstructured":"Raboud J, Blitz S, Walmsley S, Thompson C, Rourke SB, Loutfy MR. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-na\u00efve HIV-infected individuals initiating combination antiretroviral therapy. HIV Clin Trials. 2010, 11:340-50. 10.1310\/hct1106-340","journal-title":"HIV Clin Trials"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-011-0124-3","article-title":"Gender specific differences in the immune response to infection","volume":"59","author":"McClelland EE","year":"2011","unstructured":"McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz). 2011, 59:203-13. 10.1007\/s00005-011-0124-3","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201200099","article-title":"Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases","volume":"34","author":"Klein SL","year":"2012","unstructured":"Klein SL. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays. 2012, 34:1050-9. 10.1002\/bies.201200099","journal-title":"Bioessays"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27677","article-title":"Association of viral load with age, gender, disease severity, and death in severe acute respiratory syndrome coronavirus 2 variants","volume":"94","author":"Acer \u00d6","year":"2022","unstructured":"Acer \u00d6, Gen\u00e7 Bah\u00e7e Y, \u00d6z\u00fcdo\u011fru O. Association of viral load with age, gender, disease severity, and death in severe acute respiratory syndrome coronavirus 2 variants. J Med Virol. 2022, 94:3063-9. 10.1002\/jmv.27677","journal-title":"J Med Virol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-021-01677-w","article-title":"Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis","author":"Zintel S","year":"2022","unstructured":"Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis. Z Gesundh Wiss. 2022, 1-25. 10.1007\/s10389-021-01677-w","journal-title":"Z Gesundh Wiss"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/circ.148.suppl_1.15228","article-title":"Abstract 15228: Impact of gender and left ventricular ejection fraction on health-related quality of life and its change in patients with heart failure","author":"Jang JH","year":"2023","unstructured":"Jang JH, Kim DY, Shin SH. Abstract 15228: Impact of gender and left ventricular ejection fraction on health-related quality of life and its change in patients with heart failure. Circulation. 2023, 148. 10.1161\/circ.148.suppl_1.15228","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59663","article-title":"Gender disparities in cardiovascular disease and their management: a review","volume":"16","author":"Betai D","year":"2024","unstructured":"Betai D, Ahmed AS, Saxena P, et al.. Gender disparities in cardiovascular disease and their management: a review. Cureus. 2024, 16:e59663. 10.7759\/cureus.59663","journal-title":"Cureus"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies","volume":"20","author":"Schierhout G","year":"2020","unstructured":"Schierhout G, McGregor S, Gessain A, et al.. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis. 2020, 20:133-43. 10.1016\/S1473-3099(19)30402-5","journal-title":"Lancet Infect Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20014","article-title":"Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection","volume":"39","author":"Dalgard O","year":"2004","unstructured":"Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology. 2004, 39:74-80. 10.1002\/hep.20014","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1902\/annals.2001.6.1.1","article-title":"The relationship between infection, inflammation, and cardiovascular disease: an overview","volume":"6","author":"Lowe GD","year":"2001","unstructured":"Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol. 2001, 6:1-8. 10.1902\/annals.2001.6.1.1","journal-title":"Ann Periodontol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.320873","article-title":"Emerging viral infections and the potential impact on hypertension, cardiovascular disease, and kidney disease","volume":"130","author":"Savedchuk S","year":"2022","unstructured":"Savedchuk S, Raslan R, Nystrom S, Sparks MA. Emerging viral infections and the potential impact on hypertension, cardiovascular disease, and kidney disease. Circ Res. 2022, 130:1618-41. 10.1161\/CIRCRESAHA.122.320873","journal-title":"Circ Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.061183","article-title":"Severe infection and risk of cardiovascular disease: a multicohort study","volume":"147","author":"Sipil\u00e4 PN","year":"2023","unstructured":"Sipil\u00e4 PN, Lindbohm JV, Batty GD, et al.. Severe infection and risk of cardiovascular disease: a multicohort study. Circulation. 2023, 147:1582-93. 10.1161\/CIRCULATIONAHA.122.061183","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00914-4","article-title":"Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study","volume":"27","author":"Dos Santos DN","year":"2021","unstructured":"Dos Santos DN, S\u00e1 KN, Queir\u00f3s FC, et al.. Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study. J Neurovirol. 2021, 27:838-48. 10.1007\/s13365-020-00914-4","journal-title":"J Neurovirol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq326","article-title":"The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis","volume":"173","author":"Landrum ML","year":"2011","unstructured":"Landrum ML, Hullsiek KH, Chun HM, et al.. The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis. Am J Epidemiol. 2011, 173:84-93. 10.1093\/aje\/kwq326","journal-title":"Am J Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420513-association-of-oncogenic-viral-infections-with-cardiovascular-risk-and-health-outcomes-a-cross-sectional-study-in-south-asian-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T09:08:39Z","timestamp":1761383319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420513-association-of-oncogenic-viral-infections-with-cardiovascular-risk-and-health-outcomes-a-cross-sectional-study-in-south-asian-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.95369","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,25]]}}}